Anaphylaxis is an emergency condition. According to the latest international guidelines, early recognition and treatment with intramuscular epinephrine are associated with increased survival. Objective: To determine the level of knowledge of pediatricians in a tertiary Pediatric Hospital about the diagnostic criteria and treatment of anaphylaxis. Material and Method: A cross-sectional descriptive study was conducted, designing, applying, and validating an anonymous survey to physicians with complete residency in pediatrics who are on call at a third level hospital. The statistical analysis was made using the SPSS v.21 software, presenting measures of central tendency (median, range, and frequency table) and Chi-square test for comparison. A value of p < 0.05 was considered significant. Results: 71 physicians completed the survey with a median of three years after the end of residency.35% of them identified all clinical criteria, 99% (70) indicated epinephrine, 73% chose the intramuscular route, and 55% indicated the correct dose. Only 48% of responders chose the dose and administration route correctly. In general, 21% recognized anaphylaxis and used epinephrine correctly. Physicians with less than five years of experience performed better in the intramuscular administration of epinephrine (83% vs 52% p = 0.005) and in the detection of gastrointestinal symptoms (60% vs 35% p = 0.043). Conclusions: There are difficulties in the identification and proper management of anaphylaxis by pediatricians of a tertiary Pediatric Hospital in a theoretical clinical setting. Although most of pediatricians chose epinephrine as a first-line drug, half of them did not indicate it correctly, and only one-third recognized anaphylaxis in all scenarios.
Introduction
Anaphylaxis is an emergency in which early recognition and management save lives. The clinical criteria recognition (table 1) defined in 2005 during an expert meeting of the U.S. National Institutes of Health (NIH) (3) and the intramuscular epinephrine as the drug of choice and first treatment action are key in reversing symptoms according to the latest recommendations (4) (5) (6) (7) .
In the last 15 years, it has been observed an anaphylaxis incidence increase in the USA and Europe (8, 9) . Between 2008 and 2014, consultations due to anaphylaxis increased by 147% (10) in the US pediatric emergency departments (PEDS), in addition to an increase in food allergies in children between 1997 and 2007 (11) .
PEDS are often the first place of anaphylaxis care. Despite the increase in the number of cases, there are still difficulties in the recognition and proper management of the condition (12) (13) (14) (15) (16) . Faced with this reality, we decided to conduct a survey to pediatricians who assist emergencies in a tertiary Pediatric Hospital in order to evaluate the knowledge about the latest recommendations (4) (5) (6) (7) on anaphylaxis management and recognition.
Material and Method
Descriptive cross-sectional study, conducted through the survey design and implementation on August 24, 2016 at the Hospital de Pediatría "Prof. Dr. Juan P. Garrahan", a tertiary, 534-bed Pediatric hospital (Ciudad Autónoma de Buenos Aires (CABA), Argentina), with about 90,000 Pediatric Emergency Department visits (PED) per year and 300 Intermediate and Moderate Care (IMC) beds. Population: Pediatricians (physicians with complete pediatric residency) who do shifts* in the IMC and PED units. Those physicians who were on medical leave at the time of the survey as well as PED fellows and staff physicians** were excluded. The number of service years after completing the pediatric residency was recorded.
The survey (Figure 1 ) was self-administered and anonymous. In order to avoid consultations with other colleagues or bibliographic sources, surveys were conducted under direct observation by the same operator. The survey was elaborated based on other published surveys (17, 18) and was adapted to our objective. The design was carried out by senior PED physicians. In order to validate it, four physicians with experience in caring for patients in emergency situations, who did not participate in the study, received the survey and their suggestions led to the final version (face validity) which consists of nine items of multiple-choice and short answer questions. The items comprise three dimensions, operator experience (two items), pharmacological management (three items), and clinical picture identification (four items). Informed consent was requested.
The study was conducted on a single day for eight consecutive hours in order to prevent dissemination of the content. It was given in a sealed envelope to ensure anonymity. Consent was recorded on a separate sheet to ensure confidentiality. In order to reduce information bias and to improve the instrument reliability, a single operator was responsible for administering the survey. For statistical analysis, the SPSSv.21 statistical software was used; for numerical and categorical variables, measures of central tendency were used (median, range, and frequencies table), and for their comparison, Chi-square test was used. A p-< 0.05 value was considered statistically significant.
Results
At the "Prof. Dr. Juan P. Garrahan" pediatric hospital, 100 physicians with complete pediatric residency perform shifts in the IMC and PED units. 71 physicians were surveyed and 29 were excluded (18 were on medical leave, three were unavailable, five were PED staff physicians, and three were PEDs fellows). 67 out of 71 answered the survey completely. The median of years since the end of residence was three years (0.1-24 years). 69% (49) reported having ever witnessed an anaphylaxis episode in their daily practice.
Four questions were asked to assess knowledge of the diagnostic criteria published in 2005 by NIH (1) (table 2). Only 35% (25) recognized all anaphylaxis criteria.
Although 99% (70) choose epinephrine as the firstchoice drug for treatment (table 3) , only 73% (52) indicated it by the recommended route (intramuscular), and 55% (39) at the appropriate dose (0.01 mg/kg). When we fully analyzed the epinephrine indication (choice, dose, and route), we observed that 48% (34) answered correctly.
When analyzing globally, both the clinical recognition of anaphylaxis and the correct choice and use of epinephrine, we noticed that only 21% (15) of the respondents answered adequately.
Finally, when we compare anaphylaxis management according to the respondent experience (table 4), SBP= systolic blood pressure. Low systolic blood pressure for children is defined as less than 70 mmHg from 1 month to 1 year, less than (70 mm Hg + (2 x age]) from 1 to 10 years, and less than 90 mmHg from 11 to 17 years. NIH clinical criteria: Skin/mucosal = involvement of the skin, mucosal tissue o both; respiratory = respiratory compromise; gastrointestinal = persistent gastrointestinal symptoms, nervous system=neurologic symptoms; cardiovascular = reduce blood pressure or associated symptoms; iM = intramuscular route; epinephrine appropriate administration = 0,01 mg/kg of epinephrine by intramuscular route. *p = chi2 tests. **is not a niH criteria. we observe that those with less than five years in practice more frequently recognize the association of persistent gastrointestinal symptoms and mucocutaneous symptoms (60% vs 35% p = 0.043), and administer epinephrine intramuscularly more frequently (83% vs 52% p = 0.006).
Discussion
A study published by Campbell et al. (26) in 2012 showed that the diagnostic criteria established in 2005 by the National Institute of Allergy and Infectious Diseases and the Food Allergy and Anaphylaxis Network (NIAID/FAAN) have 96.5% of diagnostic sensitivity and 82.4% of specificity. However, gaps in the anaphylaxis recognition are still a global problem today.
Currently, the WHO International Classification of Diseases (ICD-9 and ICD-10) for anaphylaxis generates confusion among users since it considers hypotension or shock in its definition and does not include other NIH criteria, thus contributing to the underdiagnosis (27, 28) . Possibly, this situation changes soon after the ICD-11 publication which has a new section on "Allergic and hypersensitivity conditions" within the chapter on "Immune system disorders" which recognizes anaphylaxis as a clinical condition for the first time (29, 30) .
Another frequent obstacle to recognition is the use of anaphylactic shock and anaphylaxis as synonyms. It should be considered that hypotension in children is rare as shown by retrospective studies in pediatric PEDS. Alvarez-Perea et al. (13) described a series of 133 children with anaphylaxis in which only 7% had shock, and Goetz et al. (14) observed that, among 211 children with anaphylaxis, only 2% had hypotension associated with other symptoms and none of them had isolated hypotension associated with allergen (NIH criterion 3).
Most surveys conducted worldwide (table 5) emphasize more the choice and appropriate administration of epinephrine than the clinical picture recognition, which leads to its administration. Our results, coinciding with the surveys conducted by Wang et al. (12) and Jacobsen et al. (31) , showed that classical presentations with skin and/or mucosa involvement, respiratory symptoms, and shock were more easily recognized than those less frequent cases with gastrointestinal involvement. When there is no skin involvement (10-20%) (32) , Jacobsen et al. (31) and Wang et al. (12) observed that only 3% and 50% of respondents, respectively, recognized the condition.
Reviewing clinical records of children treated in the PED, Alvarez Perea et al. (13) found that anaphylaxis was recognized only in 53% of cases. The remaining patients were admitted with diagnosis of urticaria, angioedema, or allergic reaction, and did not receive adequate treatment.
The use of a standardized definition, key to recognition, is scarce. In Brazil, Russell et al. (33) reported that 90% of PEDs do not use standardized criteria.
The many barriers to the proper and timely identification of anaphylaxis is still a universal public health concern. The observed results in our survey reinforce the need to increase all the necessary measures to enhance the dissemination of clinical criteria in order to improve the recognition of the condition and give way to treatment.
Another assessed aspect of the survey was the internationally recommended first-line treatment (4) (5) (6) (7) . When we compare our results regarding the choice of epinephrine as a first-line drug with other surveys on physicians (table 5), the outcomes are similar (between 85-95%). But when we observe the clinical condition management according to the data provided by retrospective studies in pediatric PEDs, Álvarez-Perea et al. (13) , Goetz et al. (14) , Wright et al. (15) , and Robinson et al. (16) report that epinephrine is administered in children only between 32% and 68% of anaphylaxis episodes. On the other hand, Álvarez-Perea et al. (13) and Wright et al. (15) described high use of corticosteroids (81% and 51%, respectively), and antihistamines (63% and 62%, respectively) as first-choice drugs. Wright et al. (15) justified this discrepancy due to the lack of anaphylaxis management protocols in PEDs, poor knowledge of treatment guidelines, and misconceptions about the safety of intramuscular epinephrine in its management.
In our study, the intramuscular route selection (73%) and the dose of 0.01 mg/kg (55%) were similar to the analyzed surveys and higher in some cases (table  5) . However, we noticed that in our results 18% chose the intravenous route and 35% administered higher doses than recommended. Cardona et al. (34) described that the intravenous epinephrine administration and the use of higher doses than recommended were associated with a higher frequency of adverse effects but did not observe higher morbidity and mortality.
Finally, we decided to evaluate whether the professional years in practice are related to adequate recognition and treatment according to the latest recommendations (4) (5) (6) (7) . As Coletti et al. (17) , we found that physicians with fewer years in practice indicate in greater proportion intramuscular epinephrine. Conversely, Grossman et al. (18) did not find an association with the years in practice but did with those who had carried out residency programs. Our analysis also shows that physicians with fewer years in practice recognized gastrointestinal symptoms better. These differences could be due to an increase in the number of publications on anaphylaxis in children -Fustiñana al et al the subject in recent years (30) , to a more recent training, to the incorporation of the subject in the latest emergency congresses in the region, and in the curriculum of residents.
There are certain limitations in our study; surveys do not always reflect action in real situations, and the answers to multiple-choice surveys on a specific topic can be biased. However, the survey results have allowed us to take educational and training measures aimed at the institution's health personnel.
Conclusion
There are difficulties in the anaphylaxis identification and appropriate management by pediatricians from a tertiary hospital in a theoretical setting. Only one-third of respondents (35%) were able to recognize all clinical criteria for anaphylaxis, which could imply the existence of anaphylaxis underdiagnosis. Although most of the respondents chose epinephrine as first-line drug, more than half of them used it incorrectly, with the risks involved (undertreatment and/or adverse effects). Finally, only 21% identified and treated adequately the condition. These results suggest the development of educational strategies and clinical care protocols to optimize the management of this type of events that require urgent action.
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